Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Le Journal Medical Libanais. the Lebanese Medical Journal|August 10, 2004
[Indications for therapeutic activity of cyclosporine]Chebl Mourani, Samir Mallat, Cathia HachemLe Journal Medical Libanais. the Lebanese Medical Journal|November 24, 2015
[Immunosuppressive protocols in kidney transplantation: with or without induction?]Dania Nehme Chelala, Chebl Mourani, Maroun Moukarzel, et al.Le Journal Medical Libanais. the Lebanese Medical Journal|November 24, 2015
DONOR SPECIFIC ANTI-HLA ANTIBODIES DETECTION AND IMPACT IN KIDNEY TRANSPLANTATIONHiba Azar, Chebl Mourani, Dania Nehme Chelala, et al.Le Journal Medical Libanais. the Lebanese Medical Journal|July 14, 2006
[Cardiogenic shock revealing heart disease in infancy and childhood: a Lebanese multicentric study]Ghassan Chéhab, Zakhia Saliba, Philippe Chédid, et al.Le Journal Medical Libanais. the Lebanese Medical Journal|July 14, 2006
Salmonella typhi in a child with urinary tract infection and urolithiasisChebl Mourani, Georges Hagge, Samir G Mallat, et al.Le Journal Medical Libanais. the Lebanese Medical Journal|November 24, 2015
[Kidney transplantation in pediatric patients: 18-year experience at Hôtel-Dieu de France]Chebl Mourani, Maroun Moukarzel, Bernard Gerbaka, et al.Le Journal Medical Libanais. the Lebanese Medical Journal|November 24, 2015
CYTOMEGALOVIRUS INFECTION POST KIDNEY TRANSPLANT: What Should We Know Now?Samir Mallat, Maroun Moukarzel, David Atallah, et al.Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|November 6, 2019
Same Donor Laparoscopic Liver and Kidney Procurement for Sequential Living Donor Liver-Kidney Transplantation in Primary Hyperoxaluria Type IRoberta Angelico, Isabella Guzzo, Marco Pellicciaro, et al.Kidney International|December 18, 2009
Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcomeJérôme Harambat, Sonia Fargue, Cécile Acquaviva, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 17, 2022
Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C TrialMini Michael, Jaap W Groothoff, Hadas Shasha-Lavsky, et al.Pageof 2